MKI
Showing 1 - 23 of 23
Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,
Active, not recruiting
- Radiomics
- +4 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023
Differentiated Thyroid Cancer Which is Radioactive Iodine
Completed
- Thyroid Neoplasms
- Sorafenib (Nexavar, BAY43-9006)
- Other Multikinase inhibitors
-
Birmingham, Alabama
- +33 more
Jun 6, 2021
Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with sorafenib/lenvatinib and iodion-125 seeds
Recruiting
- Hepatocellular Carcinoma Non-resectable
- TACE combined with sorafenib/lenvatinib and iodion-125 seeds brachytherapy
- TACE combined with sorafenib/lenvatinib
-
Guangzhou, Guangdong, Chinathe Second Affiliated Hospital of Guangzhou Medical University
Jul 27, 2021
Intestinal Metabolic Reprogramming asKey Mechanism of Gastric
Active, not recruiting
- Obesity
- +4 more
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital of UPMC
Aug 2, 2022
Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)
Not yet recruiting
- Anal Squamous Cell Carcinoma
- +7 more
- Regorafenib in combination with Tislelizumab
- (no location specified)
Oct 12, 2022
Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Badalona, Sant Cugat Del Vallès, Barcelona (Elacestrant)
Completed
- Breast Cancer
- Hormone Receptor Positive Breast Carcinoma
-
Badalona, Barcelona, Spain
- +3 more
Oct 25, 2022
Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma Trial in France (Blood sampling to build population
Recruiting
- Digestive Cancer
- +4 more
- Blood sampling to build population pharmacokinetics model
-
Auxerre, France
- +23 more
Aug 30, 2022
Molecular Predictors of Resistance and Response to Regorafenib
Completed
- Metastatic Colorectal Cancer
-
Carshalton, Surrey, United KingdomThe Royal Marsden NHS Foundation Trust London and Surrey
Apr 30, 2021
Infectious Disease, Yellow Fever, Japanese Encephalitis Trial (Stamaril, Imojev, Ixiaro)
Not yet recruiting
- Infectious Disease
- +3 more
- Stamaril
- +2 more
- (no location specified)
Oct 3, 2022
Following SARS-CoV-2 (Covid-19) Vaccinations
Recruiting
- Covid-19
- Subjects Vaccinated Against Covid-19
- Change in SARS-CoV-2 Antibody Levels
-
Southlake, TexasSouthlake Diagnostics, Inc.
Aug 26, 2022
Non-Infectious Uveitis Trial in United States (FAI Insert administered using the Mk II inserter, FAI Insert administered using
Completed
- Non-Infectious Uveitis
- FAI Insert administered using the Mk II inserter
- FAI Insert administered using the Mk I inserter
-
Colorado Springs, Colorado
- +5 more
Apr 22, 2020
Breast Cancer Trial in Stanford (Vitamin D)
Terminated
- Breast Cancer
- Vitamin D
-
Stanford, CaliforniaStanford University Cancer Institute
Mar 26, 2019
European Regulatory Science on Tobacco: Policy Implementation to
Completed
- Tobacco Dependence
- Questionnaire
-
Brussels, BelgiumEuropean Network For Smoking and Tobacco Prevention
Feb 19, 2019
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GW856553, Placebo, Seretide)
Completed
- Pulmonary Disease, Chronic Obstructive
- GW856553
- +2 more
-
Tallinn, Estonia
- +30 more
Aug 17, 2017
Ki67 Index in Hormone Receptor-positive Breast Cancer
Completed
- Breast Cancer
-
Seoul, Korea, Republic ofSamsung Medical Center
Apr 27, 2017
Pulmonary Disease, Chronic Obstructive, COPD (COPD) Trial in Hannover, Grosshansdorf, Berlin (GW856553)
Completed
- Pulmonary Disease, Chronic Obstructive
- Chronic Obstructive Pulmonary Disease (COPD)
-
Hannover, Niedersachsen, Germany
- +2 more
May 31, 2012